Literature DB >> 33485931

Linc-ROR promotes mesenchymal stem cells chondrogenesis and cartilage formation via regulating SOX9 expression.

L Feng1, Z M Yang1, Y C Li1, H X Wang1, J H T Lo1, X T Zhang1, G Li2.   

Abstract

OBJECTIVE: The present study is to characterize the role of long intergenic non-coding RNA, regulator of reprogramming (linc-ROR) in bone marrow mesenchymal stem cell (BMSCs) chondrogenesis, cartilage formation and OA development.
METHODS: Linc-ROR expression pattern in articular cartilage tissue sample from OA patients were studied by real-time PCR. Linc-ROR lentivirus mediated BMSCs were constructed. In vitro micromass cultured BMSCs chondrogenesis or in vivo MeHA hydrogel encapsulated BMSCs cartilage formation activity were studied. Linc-ROR associating miRNAs which repressed SOX9 expression were characterized by luciferase assay, real-time PCR and Western blot. Linc-ROR was co-transfected with miRNAs into BMSCs to study its rescue effect on SOX9 expression and chondrogenesis activity.
RESULTS: Linc-ROR was down-regulated in articular cartilage tissue from OA patients and was positively correlated with the expression level of SOX9 (R2 = 0.43). Linc-ROR expression was upregulated during BMSCs chondrogenesis. Linc-ROR ectopic expression significantly promoted in vitro BMSCs chondrogenesis and in vivo cartilage formation activities as revealed by safranin O, alcian blue and COL II staining. The mRNA expression level of chondrogenesis markers including COL II, SOX9 and ACAN were increased, and the hypertrophy markers MMP13 and COL X were decreased upon linc-ROR overexpression in BMSCs. Linc-ROR functioned as a miRNA sponge for miR-138 and miR-145. Both miR-138 and miR-145 suppressed BMSCs chondrogenesis activity and SOX9 expression, while co-expression of linc-ROR displayed a rescuing effect.
CONCLUSIONS: Taken together, linc-ROR modulated BMSCs chondrogenesis differentiation and cartilage formation by acting as a competing endogenous RNA for miR-138 and miR-145 and activating SOX9 expression. Linc-ROR could be considered as a new diagnostic and therapeutic target for OA treatment.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  BMSCs; Chondrogenesis; Hydrogels; Linc-ROR

Mesh:

Substances:

Year:  2021        PMID: 33485931     DOI: 10.1016/j.joca.2020.12.020

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  5 in total

1.  Sesamin Promotes Osteoporotic Fracture Healing by Activating Chondrogenesis and Angiogenesis Pathways.

Authors:  Zhengmeng Yang; Lu Feng; Ming Wang; Yucong Li; Shanshan Bai; Xuan Lu; Haixing Wang; Xiaoting Zhang; Yaofeng Wang; Sien Lin; Micky D Tortorella; Gang Li
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

2.  MicroRNA-378 contributes to osteoarthritis by regulating chondrocyte autophagy and bone marrow mesenchymal stem cell chondrogenesis.

Authors:  Lu Feng; Zhengmeng Yang; Yucong Li; Qi Pan; Xiaoting Zhang; Xiaomin Wu; Jessica Hiu Tung Lo; Haixing Wang; Shanshan Bai; Xuan Lu; Ming Wang; Sien Lin; Xiaohua Pan; Gang Li
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-23       Impact factor: 10.183

3.  DANCR Mediates the Rescuing Effects of Sesamin on Postmenopausal Osteoporosis Treatment via Orchestrating Osteogenesis and Osteoclastogenesis.

Authors:  Zhengmeng Yang; Lu Feng; Haixing Wang; Yucong Li; Jessica Hiu Tung Lo; Xiaoting Zhang; Xuan Lu; Yaofeng Wang; Sien Lin; Micky D Tortorella; Gang Li
Journal:  Nutrients       Date:  2021-12-13       Impact factor: 5.717

4.  LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis.

Authors:  Yin Fu; Xiaoyang Hu; Yanyu Gao; Kai Li; Qiang Fu; Qingpeng Liu; Dan Liu; Zhijia Zhang; Jiutao Qiao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  Epigenetic Regulation in Knee Osteoarthritis.

Authors:  Zhengyu Cai; Teng Long; Yaochao Zhao; Ruixin Lin; You Wang
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.